Neurotherapeutics
Q1 Journal
Open Access
Journal
Country
Netherlands
Western Europe
Subject Area and Category
Medicine
└
Neurology (clinical)
Q1
└
Pharmacology
Q1
└
Pharmacology (medical)
Q1
Publisher
SJR 2025
2.384
Q1
SJR Score
H-Index
152
Citations / Doc (2yr)
7.11
Total Docs. (latest)
251
Total Citations (3yr)
3,442
Publication type
Journals
ISSN
19337213, 18787479
Coverage
2007-2026
Journal Rank
#1,047
Subject Categories
Neurology (clinical)
Q1
Pharmacology
Q1
Pharmacology (medical)
Q1
Subject Areas
Aims & Scope
Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT).
Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.
The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.
Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 251 |
| Total Docs. (3 years) | 421 |
| Total Refs. | 19,783 |
| Total Citations (3 years) | 3,442 |
| Citable Docs. (3 years) | 399 |
| Citations / Doc. (2 years) | 7.11 |
| Ref. / Doc. | 78.82 |
| % Female | 44.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.